Bunzl acquires New Zealand business, Obex Medical Holdings

bunzl plc

Bunzl plc (LON:BNZL), the specialist international distribution and services Group, has announced that it has recently entered into an agreement to acquire Obex Medical Holdings, a medical distribution business serving hospitals and other healthcare providers in New Zealand, with revenue in 2020 of c.NZD 51 million (c.£ 27 million).  Obex Medical Holdings supplies a broad range of healthcare equipment and devices, and it is headquartered in Auckland. Completion of the acquisition is expected to take place at the beginning of June.

Commenting on the acquisition, Frank van Zanten, Chief Executive Officer of Bunzl, said:

“I am pleased to be able to announce our fourth acquisition of 2021. Obex Medical Holdings is a strong business with an experienced management team that will complement and enhance Bunzl’s healthcare capabilities in Australasia. The Group’s acquisition pipeline remains active and a number of discussions are ongoing.”

Share on:

Latest Company News

Bunzl Plc reports steady Q3 trading, reaffirms 2025 outlook

Bunzl plc has reported a 0.6% increase in Q3 revenue at constant exchange rates, with underlying revenue up 0.4% despite challenging market conditions.

Bunzl Plc expands with acquisitions in Ireland and Spain

Bunzl =has completed the acquisitions of Caterline Catering Equipment Ltd in Ireland and Anta y Jesús, S.L.U in Spain, each generating revenue of €6 million (£5 million) in 2024.

Bunzl Plc expands with five acquisitions across Spain, Mexico, Brazil and Chile

Bunzl has announced the completion of two new acquisitions, Quindesur in Spain and Gisa in Mexico, alongside the previously disclosed purchases of Solupack in Brazil and Hospitalia in Chile.

Bunzl Plc enters Chilean healthcare and acquires Dutch medical firm

Bunzl plc expands its global footprint with acquisitions in Chile and the Netherlands, strengthening its presence in the healthcare distribution sector.

Bunzl Plc cuts 2025 outlook after profit decline

Bunzl plc provides a trading update for Q1 2025, revealing challenges in North America, revenue growth shifts, and a revised outlook for the year ahead.

Bunzl Plc reports record acquisition spend, reiterates 2025 guidance

Bunzl plc reports impressive annual results for 2024, showcasing strong revenue growth, expanded operating margins, and a record year for acquisitions.

    Search

    Search